Univest
Univest
  • Markets

Marico vs Emami: Share Price, PE and ROE Compared

  • August 13, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Marico vs Emami: Share Price, PE and ROE Compared

Marico MCap Rs 1,10,714 Cr, PE 56.73x, ROE 41.85%, Div 0.47%. Emami MCap Rs 17,327 Cr, PE 23.11x, ROE 26.51%, Div 2.52%.

Quick Answer

Marico and Emami are both FMCG consumer companies. Marico at Rs 1.11 lakh Cr is over 6 times larger with an exceptional ROE of 41.85% at PE 56.73x. Emami at Rs 17,327 Cr trades at a much cheaper PE of 23.11x with ROE 26.51% and a higher dividend of 2.52%. Emami’s lower PE relative to quality may interest value-oriented investors.

The Marico vs Emami question comes up often among investors who follow the FMCG personal care space in India. Marico MCap Rs 1,10,714 Cr, PE 56. 73x, ROE 41. This article goes through what each company does, their latest financial performance, and the key numbers that matter for anyone evaluating Marico vs Emami as a research exercise.

All data cited here is sourced from publicly available company filings. Note: Size gap: approximately 6.4x. Verify the latest prices and fundamentals on NSE or BSE before acting on any information.

Table of Contents

Toggle
  • Marico vs Emami: Company Overview and Market Presence
  • Marico vs Emami: Business Mix and Revenue Sources
  • Marico vs Emami: Financial Results and Key Ratios
  • Marico vs Emami: Valuation and What the Market Is Pricing In
  • Marico vs Emami: Side-by-Side Comparison
  • What Should Investors Know About the Marico vs Emami Choice
  • Conclusion
  • Frequently Asked Questions
    • What does Marico do?
    • What does Emami do?
    • Which is larger in the Marico vs Emami comparison?
    • How do PE ratios compare in Marico vs Emami?
    • What is the ROE of Marico?
    • Does Emami pay dividends?
    • How should I evaluate FMCG personal care stocks?

Marico vs Emami: Company Overview and Market Presence

Marico operates in the FMCG personal care segment and is listed on Indian exchanges. Marico MCap Rs 1,10,714 Cr, PE 56 The company has built its market position over the years through its core offerings to customers across India.

Click Here – Get Free Investment Predictions

Emami is the other side of this Marico vs Emami comparison. 73x, ROE 41 It competes in the same FMCG personal care space, though its scale and strategy may differ significantly from Marico’s approach.

When investors look at the Marico vs Emami pair, market capitalisation is usually the first filter. Marico MCap Rs 1,10,714 Cr, PE 56. 73x, ROE 41. The size difference, if any, tells you something about liquidity and institutional ownership patterns.

Marico vs Emami: Business Mix and Revenue Sources

To understand the Marico vs Emami comparison fully, you need to look at how each company makes money. Marico’s revenue comes from its core FMCG personal care operations. Marico earns from the FMCG personal care segment.

Emami similarly derives its earnings from the FMCG personal care space. Emami operates in the FMCG personal care space. The product or service mix of the two companies can be similar or quite different depending on which subsegments each one serves.

Marico vs Emami: Financial Results and Key Ratios

This is where the Marico vs Emami comparison gets concrete. Return on equity, price-to-earnings ratio and market capitalisation are three metrics that help frame the relative position of each stock.

Marico MCap Rs 1,10,714 Cr, PE 56 The profitability and efficiency ratios here reflect the latest available data from public filings.

73x, ROE 41 Investors should note that Size gap: approximately 6.4x.

Compare Marico and Emami on the Univest Screener

Marico vs Emami: Valuation and What the Market Is Pricing In

Valuation is a core part of any Marico vs Emami analysis. A high PE ratio can signal growth expectations or thin earnings. A low PE may indicate value or a business under stress. Neither is automatically good or bad without context.

Marico MCap Rs 1,10,714 Cr, PE 56.73x, ROE 41.85%, Div 0.47%. Emami MCap Rs 17,327 Cr, PE 23.11x, ROE 26.51%, Div 2.52%. The Marico vs Emami stock data above reflects figures sourced from publicly available data. Prices change daily, so treat this as a starting point for your own research rather than a definitive trading signal.

Dividend yield is another data point worth checking in the Marico vs Emami pair. Some investors prioritise income alongside capital appreciation, and a consistent dividend track record can be a sign of earnings quality and management confidence in the cash flow.

Marico vs Emami: Side-by-Side Comparison

The table below captures the most relevant metrics side by side for the Marico vs Emami comparison.

Parameter Marico Emami
MCap Rs 1,10,714 Cr Rs 17,327 Cr
PE 56.73x 23.11x
ROE 41.85% 26.51%
Div 0.47% 2.52%

What Should Investors Know About the Marico vs Emami Choice

Every Marico vs Emami research exercise should go beyond just looking at the current share price. The sector outlook for FMCG personal care companies, the trajectory of earnings growth, debt levels and management quality all feed into a complete picture.

For the Marico vs Emami pair specifically: Marico MCap Rs 1,10,714 Cr, PE 56. 73x, ROE 41. These numbers are a starting point. Investors should also look at the trend over four to eight quarters rather than just the latest standalone figure, since one strong quarter does not always reflect the underlying business quality.

If you are building a portfolio allocation decision around the Marico vs Emami comparison, consider the risk profile of your overall portfolio first. Both companies operate in FMCG personal care, which carries its own sector-specific risks including regulatory changes, commodity cost pressure, competitive intensity and macroeconomic sensitivity.

Conclusion

The Marico vs Emami comparison comes down to this: Marico and Emami are both listed Indian companies in the FMCG personal care space, but they differ in scale, valuation, and financial profile. Marico MCap Rs 1,10,714 Cr, PE 56. 73x, ROE 41.

Marico MCap Rs 1,10,714 Cr, PE 56.73x, ROE 41.85%, Div 0.47%. Emami MCap Rs 17,327 Cr, PE 23.11x, ROE 26.51%, Div 2.52%. Before taking any position in either stock, verify the latest fundamentals on NSE or BSE and consult a SEBI-registered investment advisor (registration number INH000013776).

Download the Univest iOS App or Univest Android App to track Marico and Emami live and get analyst-backed stock recommendations every day.

Disclaimer: Data and figures in this article are sourced from publicly available information and may not be fully accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice from Univest (SEBI RA INH000013776).

Frequently Asked Questions

What does Marico do?

Ans. Marico is a listed Indian company in the FMCG personal care segment. For the latest business updates, visit univest.in.

What does Emami do?

Ans. Emami is a listed Indian company in the FMCG personal care segment. For the latest business updates, visit univest.in.

Which is larger in the Marico vs Emami comparison?

Ans. Based on current market cap data: Marico MCap Rs 1,10,714 Cr, PE 56. Verify the latest figures on NSE or BSE.

How do PE ratios compare in Marico vs Emami?

Ans. The PE ratio comparison is covered in the data table above. Verify current figures from NSE or BSE before investing.

What is the ROE of Marico?

Ans. The ROE of Marico is mentioned in the data table above. Verify from the latest quarterly filings.

Does Emami pay dividends?

Ans. Dividend yield information for Emami is included in the comparison above. Verify from NSE or BSE.

How should I evaluate FMCG personal care stocks?

Ans. For FMCG personal care stocks, review earnings quality, ROE trends, debt levels and sector outlook. Consult a SEBI-registered advisor (INH000013776) before investing.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply